Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1954 5
1955 3
1956 1
1957 2
1958 1
1959 1
1961 2
1964 3
1965 3
1967 2
1968 3
1969 2
1970 4
1971 6
1973 2
1974 3
1976 2
1977 1
1979 2
1980 1
1984 1
1985 1
1987 1
1988 1
1989 2
1990 2
1991 2
1992 8
1993 9
1994 7
1995 2
1996 9
1997 1
1998 3
1999 6
2000 7
2001 6
2002 5
2003 3
2004 6
2005 6
2006 12
2007 6
2008 4
2009 4
2010 3
2011 4
2012 10
2013 7
2014 5
2015 7
2016 5
2017 6
2018 5
2019 4
2020 7
2021 18
2022 15
2023 15
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis.
Ciapponi A, Berrueta M, P K Parker E, Bardach A, Mazzoni A, Anderson SA, Argento FJ, Ballivian J, Bok K, Comandé D, Goucher E, Kampmann B, Munoz FM, Rodriguez Cairoli F, Santa María V, Stergachis AS, Voss G, Xiong X, Zamora N, Zaraa S, Buekens PM. Ciapponi A, et al. Among authors: voss g. Vaccine. 2023 Jun 7;41(25):3688-3700. doi: 10.1016/j.vaccine.2023.03.038. Epub 2023 Mar 27. Vaccine. 2023. PMID: 37012114 Free PMC article. Review.
Toxicology of phosphamidon.
Sachsse KR, Voss G. Sachsse KR, et al. Among authors: voss g. Residue Rev. 1971;37:61-88. doi: 10.1007/978-1-4615-8473-5_5. Residue Rev. 1971. PMID: 4937707 Review. No abstract available.
Phosphamidon residue methods.
Voss G, Baunok I, Geissbühler H. Voss G, et al. Residue Rev. 1971;37:101-32. doi: 10.1007/978-1-4615-8473-5_7. Residue Rev. 1971. PMID: 4937706 Review. No abstract available.
The virtual articulator.
Bisler A, Bockholt U, Kordass B, Suchan M, Voss G. Bisler A, et al. Among authors: voss g. Int J Comput Dent. 2002 Apr-Jul;5(2-3):101-6. Int J Comput Dent. 2002. PMID: 12680040 English, German.
Progress and challenges in TB vaccine development.
Voss G, Casimiro D, Neyrolles O, Williams A, Kaufmann SHE, McShane H, Hatherill M, Fletcher HA. Voss G, et al. F1000Res. 2018 Feb 16;7:199. doi: 10.12688/f1000research.13588.1. eCollection 2018. F1000Res. 2018. PMID: 29568497 Free PMC article. Review.
New hope for tuberculosis vaccines.
Olesen OF, Abdullah F, Coppens R, Gardner PJ, Ginsberg AM, Hanekom WA, Laang H, Lewinsohn DM, Loots G, Schmidt A, Vekemans J, Voss GH. Olesen OF, et al. Among authors: voss gh. Lancet Infect Dis. 2019 Jul;19(7):687-688. doi: 10.1016/S1473-3099(19)30280-4. Lancet Infect Dis. 2019. PMID: 31250810 No abstract available.
261 results